Clinical Trial Update: Metronidazole as Preoperative Therapy in CRC / FusoMetro-001 [Phase 2]

View source ↗

Summary

A Phase 2 study (FusoMetro-001) evaluating metronidazole as preoperative therapy for colorectal cancer. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Oncology Institute of Southern Switzerland | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING